Acasti Pharma reported $0 in Debt for its fiscal quarter ending in September of 2024.


Debt Change Date
Acasti Pharma USD 0 0 Sep/2024
Addus HomeCare USD 169.06M 29.68M Jun/2025
Amarin USD 0 0 Mar/2025
Cassava Sciences USD 0 0 Dec/2024
Knight Therapeutics CAD 58.22M 109K Sep/2024
Option Care Health USD 1.1B 6.97M Jun/2025
Organigram Holdings CAD 9.15M 35.6M Jun/2025
Tilray USD 351.72M 15.26M Nov/2024